Dicloxacillin: Difference between revisions
Annhuang04 (talk | contribs) |
Annhuang04 (talk | contribs) |
||
| Line 5: | Line 5: | ||
==Adult Dosing== | ==Adult Dosing== | ||
skin infections, staphylococcal | |||
*125-500mg PO q6h (1h before or 2h after meals) | |||
osteomyelitis | |||
*250-500mg PO q6h (1h before or 2h after meals) | |||
==Pediatric Dosing== | ==Pediatric Dosing== | ||
Revision as of 02:07, 3 September 2015
General
- Type: Penicillinase-resistant penicillin
- Dosage Forms: 250,500
- Common Trade Names: dicloxacillin
Adult Dosing
skin infections, staphylococcal
- 125-500mg PO q6h (1h before or 2h after meals)
osteomyelitis
- 250-500mg PO q6h (1h before or 2h after meals)
Pediatric Dosing
Special Populations
- Pregnancy:
- Lactation:
- Renal Dosing
- Adult
- Pediatric
- Hepatic Dosing
- Adult
- Pediatric
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
Common
Pharmacology
- Half-life:
- Metabolism:
- Excretion:
- Mechanism of Action:
Antibiotic Sensitivities[1]
Key
- S susceptible/sensitive (usually)
- I intermediate (variably susceptible/resistant)
- R resistant (or not effective clinically)
- S+ synergistic with cell wall antibiotics
- U sensitive for UTI only (non systemic infection)
- X1 no data
- X2 active in vitro, but not used clinically
- X3 active in vitro, but not clinically effective for Group A strep pharyngitis or infections due to E. faecalis
- X4 active in vitro, but not clinically effective for strep pneumonia
See Also
Source
- ↑ Sanford Guide to Antimicrobial Therapy 2014